Vancouver, BC – FinCanna Capital Corp. (CSE:CALI) (OTCQB:FNNZF) (the “Company” or “FinCanna”) a royalty company for the U.S. licensed medical cannabis industry, announced today that Cultivation Technologies Inc., (CTI) its first investment in California, has achieved US$1 million in cumulative revenue since it commenced commercial operations in late January 2018.
FinCanna announced previously this week that CTI has expanded its network of dispensaries carrying Coachella™ Premium brand of cannabis concentrates and vape cartridges which features all the major concentrate types, including diamonds, sauce, shatter, batter, and sugar, with an ongoing list of strains, to ten locations including premium dispensaries across California.
“We are very pleased to see the sales performance of CTI which has translated into its first US$1 million in revenue at only a fraction of its capacity.” said Andriyko Herchak, President and CEO of FinCanna Capital. “With its sales team in place building out an ever-expanding distribution footprint, and it’s manufacturing ramping up we see a bright future as we move into the second half of 2018.”
Click here to read the original article.